It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
New COVID boosters aren’t better than old ones, small study finds

World Oct 26, 2022

New COVID boosters aren’t better than old ones, small study finds

The early results don’t mean that getting a bivalent shot has no benefit, but they do raise the question of whether the switch to a new version of the vaccine was necessary.

New Alzheimer's drug from Biogen and Eisai is just the beginning

Commentary / World Oct 4, 2022

New Alzheimer's drug from Biogen and Eisai is just the beginning

by Lisa Jarvis

A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.

Japan selects 17 projects to support vaccine manufacturing

National Oct 3, 2022

Japan selects 17 projects to support vaccine manufacturing

The move came after the coronavirus pandemic highlighted issues affecting vaccine development and production in the country.

Eisai drug's trial success raises hope for Alzheimer's prevention

World / Science & Health | ANALYSIS Sep 30, 2022

Eisai drug's trial success raises hope for Alzheimer's prevention

by Julie Steenhuysen

Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.

A Chinese mRNA COVID vaccine gets its first approval — in Indonesia

Asia Pacific / Science & Health Sep 30, 2022

A Chinese mRNA COVID vaccine gets its first approval — in Indonesia

by Stanley Widianto and Roxanne Liu

Indonesia's food and drugs agency approved the use of Walvax Biotechnology's mRNA vaccine, which has been in development for more than two years.

Shionogi says COVID-19 pill trial shows reduction in symptoms

National / Science & Health Sep 28, 2022

Shionogi says COVID-19 pill trial shows reduction in symptoms

The drug met the trial's goal of reducing five key symptoms of the omicron variant within 72 hours of onset, the company said.

Alzheimer’s progression slowed by drug in major trial

National / Science & Health Sep 28, 2022

Alzheimer’s progression slowed by drug in major trial

by Robert Langreth

The drug slowed cognitive decline in people with early Alzheimer’s by 27% over 18 months when compared with a placebo using a common rating scale.

Japan health ministry backs Pfizer and Moderna omicron boosters

National Sep 12, 2022

Japan health ministry backs Pfizer and Moderna omicron boosters

Pfizer’s omicron booster can be administered to people age 12 and over, while Moderna’s is limited to those 18 and above, the panel advised.

Why a century-old vaccine offers new hope against pathogens

World / Science & Health Aug 17, 2022

Why a century-old vaccine offers new hope against pathogens

by Roni Caryn Rabin

The B.C.G. tuberculosis vaccine may protect against COVID-19 and other infections by broadly bolstering the immune system.

Shionogi confirms efficacy of oral COVID drug for omicron subvariant

National Aug 10, 2022

Shionogi confirms efficacy of oral COVID drug for omicron subvariant

The announcement came after a health ministry panel in July postponed the granting of emergency approval for the drug.

Siga and peers rise on optimism over therapies to treat monkeypox

World / Science & Health Jul 26, 2022

Siga and peers rise on optimism over therapies to treat monkeypox

by Bre Bradham

It has been a bumpy few months for shares of firms tied to the outbreak, as investors have piled in only to rush out on uncertainty about what medicine could be needed.

Eisai says Alzheimer’s drug will get priority review in U.S.

Business / Corporate Jul 6, 2022

Eisai says Alzheimer’s drug will get priority review in U.S.

by Robert Langreth and Kanoko Matsuyama

Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.

« 1 … 6 7 8 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times